Tag Archive for: pharmaceutical conference UK

Making Pharmaceuticals, Making Nutraceuticals

Making Pharmaceuticals, Making Nutraceuticals 2026 is a leading UK conference and exhibition held on 21–22 April 2026 at the Coventry Building Society Arena. This event gathers pharmaceutical and nutraceutical professionals for free access to exhibits, conferences, and networking. Attendees can explore all three programmes—Making Pharmaceuticals, Distributing Pharmaceuticals, and Making Nutraceuticals—with a single registration.

The conference offers focused sessions on formulation, regulatory compliance, manufacturing, sustainability, packaging, distribution, functional ingredients, and quality assurance. Additionally, a theatre dedicated to APIs provides insights into sourcing, trends, and cross-industry applications.

More than 150 exhibitors showcase equipment, materials, services, logistics, compliance solutions, and ingredients. Attendees can quickly find solutions for production, supply chains, and regulatory needs. Exhibitors include multinational brands, niche innovators, and service specialists, creating a strong business marketplace. Among the exhibitions, HARKE Pharma will present pelletized excipients and actives, such as CELLETS®, TAP® and Ibuprofen DC100.

Visitor numbers show growing influence, with over 1,700 professionals attending recent editions. The audience includes formulation scientists, regulatory leaders, manufacturing directors, distribution executives, and product developers. The event promotes collaboration as pharmaceutical and nutraceutical sectors increasingly overlap.

Key opportunities include targeted networking, sponsorship exposure, and direct engagement with industry decision-makers. Furthermore, the Excellence Awards recognize innovation and sustainability in product development, manufacturing, and distribution. All eligible participants can enter the awards.

In conclusion, Making Pharmaceuticals, Making Nutraceuticals 2026 offers learning, discovery, and collaboration opportunities. It supports innovation, operational excellence, and growth across health science industries.